🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Exclusive: XYXX raises fresh funds led by Niveshaay Sambhav Fund

EntrackrEntrackr · 1y ago
Exclusive: XYXX raises fresh funds led by Niveshaay Sambhav Fund
Medial

Men-focused premium innerwear and lifestyle brand XYXX is raising Rs 30 crore ($3.6 million) in a funding round led by Niveshaay Sambhav Fund, with participation from Anicut Capital, DSG Consumer Fund, and Sauce Continuity Fund. The board at XYXX has passed a special resolution to issue 1,81,818 Series B2 CCPS at an issue price of Rs 1,650 each to raise the aforementioned sum, its regulatory filing accessed from the Registrar of Companies shows. Niveshaay Sambhav Fund will invest Rs 9.93 crore, while Anicut Capital, Sauce Continuity Fund, and DSG Consumer Partners will contribute Rs 7.95 crore, Rs 4.96 crore, and Rs 1.99 crore, respectively. The remaining amount will be invested by Singularity Growth, Selenium Trust, Veena Merchants, and Arun Venkatachalam HUF. XYXX will use these proceeds to meet the capex and working capital requirements for the ongoing operations. According to Entrackr's estimates, it will be valued at around Rs 820 crore post-allotment. XYXX is a lifestyle brand specializing in underwear, loungewear, and athleisure, crafted from premium fabrics. The company claims to have built a network of over 18,000 retailers across 50 cities. Besides its own website, XYXX retails on various marketplaces and claims to be among the top three innerwear brands. In FY23, the company launched its first store in central Mumbai and now plans to expand with new outlets in Indore and Bangalore. XYXX has raised Rs 250 crore to date, including Rs 110 crore led by Amazon Smbhav Venture Fund in May 2023. According to the startup data intelligence platform TheKredible, before this round, Sauce.vc was the largest external stakeholder, followed by DSG Consumer Fund and Amazon Smbhav Venture Fund. XYXX recorded a 25% year-on-year revenue growth, rising from Rs 105 crore in FY23 to Rs 131 crore in FY24. Simultaneously, the company trimmed its losses by 22.2% to Rs 35 crore in FY24.

Related News

Exclusive: DaMENSCH raises fresh capital from existing investors at flat valuation

EntrackrEntrackr · 1y ago
Exclusive: DaMENSCH raises fresh capital from existing investors at flat valuation
Medial

D2C men’s lifestyle brand DaMENSCH has raised Rs 21.62 crore (approximately $2.5 million) in its extended Series B round from existing investors. The fresh investment, which came after a gap of two years, appears to be a bridge round for the Bengaluru-based company. The board at DaMENSCH has passed a special resolution to issue 1,017 shares at an issue price of Rs 2,12,515 each to raise Rs 21.6 crore, its regulatory filing accessed from the Registrar of Companies shows. Existing investors including Matrix Partners, Saama Capital, Whiteboard Capital, and A91 Emerging Fund also participated during the round. The bridge round has flown in at a flat valuation. As per TheKredible estimates, it has been valued at around $70-75 million (post-money). DaMENSCH has raised over $25 million to date including its $16.6 million Series B round led by A91 Partners in February 2022. According to the startup data intelligence platform TheKredible, A91 Partners is the largest external stakeholder followed by Matrix and Saama Capital. Started in 2018 by Anurag Saboo and Gaurav Pushkar, DaMENSCH offers a range of innerwear and casual wear. It leverages its own website and marketplaces such as Amazon, Flipkart, and Myntra for distribution. While the company is yet to file its financial statements for FY24, DaMENSCH’s revenue grew 22.7% year-on-year to Rs 77.57 crore in FY23. Unlike its scale, the firm’s losses surged twofold to Rs 62.34 crore in the fiscal year ending March 2023. DaMENSCH directly competes with Bummer which secured Rs 9.25 crore from Gruhas Collective Consumer Fund in March. XYXX seems to be the most funded player in the space as it raised over $36 million to date including $13.5 million from Amazon Sambhav Fund in May last year.

Exclusive: Bare Anatomy parent Innovist kicks off Series B round

EntrackrEntrackr · 12m ago
Exclusive: Bare Anatomy parent Innovist kicks off Series B round
Medial

Innovist, the parent company of Bare Anatomy, Chemist at Play, and Sunscoop, is raising Rs 49.25 crore (approximately $5.7 million) in its Series B round. This marks the first round of investment for the Gurugram-based company in 2025. The board at Innovist has passed a special resolution to issue 72,223 Series B compulsory convertible preference shares at an issue price of Rs 6,819 each, raising Rs 49.25 crore, according to its regulatory filing accessed from the Registrar of Companies (RoC). IVen Amplifi Fund (managed by ICICI Ventures Fund) will lead the round with Rs 19.47 crore, while Mirabilis Investment Trust will contribute Rs 10.1 crore. Sauce.VC and Niveshaay Sambhav Fund will also participate, investing Rs 8.75 crore and Rs 10 crore, respectively. The fresh proceeds will be utilized for recruitment, operations, sales, marketing, and other general corporate purposes, as decided by the board. According to Entrackr estimates, the company will be valued at approximately $140 million post-allotment. This capital infusion appears to be part of a larger funding round, with the potential for additional investments that could further impact its valuation. Founded in 2018 by Rohit Chawla, Sifat Khurana, and Vimal Bhola, Innovist—formerly known as Onesto Labs—offers personal care products. It currently operates three brands: Bare Anatomy, Chemist at Play, and Sunscoop. Innovist has raised over $16 million to date, including a $7 million Series A round led by the Amazon Smbhav Venture Fund. According to the startup data intelligence platform TheKredible, prior to this round, Sauce.VC was the largest external stakeholder, followed by 72 Ventures, Accel India, and the Amazon Smbhav Fund. The company has not yet filed its annual statements for the previous fiscal year (FY24). In FY23, it reported operational revenue of Rs 36.53 crore, while its losses amounted to Rs 16.87 crore during the same period.

Exclusive: Anant Goel’s Handpickd raises fresh funds

EntrackrEntrackr · 9m ago
Exclusive: Anant Goel’s Handpickd raises fresh funds
Medial

Exclusive: Anant Goel’s Handpickd raises fresh funds Fresh produce startup Handpickd (formerly Sorted) is raising Rs 21.7 crore in an extended seed round led by Nitin Gupta and Genesia Ventures, with participation from BEENEXT and others. Fresh farm produce and supply chain startup Handpickd (previously Sorted) is raising Rs 21.7 crore in an extended seed round led by Nitin Gupta and Genesia Ventures with the participation of BEENEXT, Stargazer Ventures, Eximius Ventures, Sunrise Sunset Family Trust, and others. The Handpickd’s board passed a resolution to approve the issue of 10,547 Series Seed B CCPS at an issue price of Rs 20,566 to raise Rs 21.7 crore or around $2.5 million, according to recent filings accessed from March 2025 from the Registrar of Companies (RoC) shows. Nitin Gupta, Partner at GG Enterprises and Genesia Ventures, led the round with an investment of Rs 6.48 crore and Rs 6 crore, respectively, followed by existing investor BEENEXT, which is contributing Rs 2.16 crore. Sunrise Sunset Family Office will invest Rs 2 crore, while the remaining amount will be covered by Infinyte Club Angel Fund and Eximius Ventures, Stargazer Ventures and Ankit Agarwal. As per filings, the company has already received around Rs 10.16 crore, with the remaining amount expected to follow shortly. The Blume Venture-backed company will be valued at around Rs 300 crore or $35 million, according to Entrackr’s estimates. Founded by Anant Goel along with Nitin Gupta and Sahil Madan, Handpickd operates on a B2B2C model, delivering fresh fruits and vegetables through a tech-enabled supply chain. The company sources produce directly from local farmers and vendors, leveraging a network of micro-entrepreneurs for efficient last-mile delivery. According to startup data intelligence platform TheKredible, Handpickd has raised around $9 million from investors including BEENEXT, Blume Ventures, Kunal Bahl, Rohit Kumar Bansal. The company recorded over 2.3X year-on-year growth in operating revenue, rising to Rs 17.5 crore in FY24 from Rs 7.4 crore in FY23. Its losses remained flat at Rs 2.1 crore during the fiscal year ending March 2024. Handpickd competes with other farm-to-fork funded startups including Otipy ($49 million), Fraazo ($61 million), Deep Rooted ($20 million) which shut their operations. Handpickd also competes with Kareena Kapoor-backed startup Pluckk which is set to raise $10 million.

Exclusive: Consumer lending startup Fibe raises $66 Mn

EntrackrEntrackr · 1y ago
Exclusive: Consumer lending startup Fibe raises $66 Mn
Medial

Digital lending platform Fibe (formerly EarlySalary) has raised Rs 547 crore or $66 million in Series E round led by TPG’s The Rise Fund and Kabira Holdings. This is the first round of investments for the Pune-based company in the past two years. The board at Five has passed a special resolution to issue 5,46,75,600 Series E CCPS at an issue price of Rs 100 each to raise Rs 547 crore, its regulatory filing accessed from the RoC shows. The Rise Fund led the round with Rs 133 crore while Kabira Holdings put in Rs 125 crore. Eight Road Ventures, Norwest Capital, and Trifecta participated with Rs 41.6 crore, Rs 62.5 crore and Rs 55 crore, respectively. Amara Partners and Chirate also invested Rs 29.17 crore and Rs 100 crore. According to filings, the company will use these funds for expansion and growth as per the business plan duly adopted by the board. This is a developing story…

Exclusive: DrinkPrime raises fresh money at 30% valuation premium

EntrackrEntrackr · 5d ago
Exclusive: DrinkPrime raises fresh money at 30% valuation premium
Medial

Exclusive: DrinkPrime raises fresh money at 30% valuation premium DrinkPrime, a subscription-based reverse osmosis (RO) water supplying startup, has raised Rs 20 crore in fresh funding from Artha Venture Fund and Mirabilis Investment Trust. According to DrinkPrime’s filings with the Registrar of Companies (RoC), its board approved the allotment of 21,718 Series A3 CCPS and 10 equity shares at an issue price of Rs 9,205 per share to raise Rs 20 crore. Artha Venture Fund and Mirabilis Investment Trust have invested Rs 10 crore during the round. According to the filing, the proceeds will be utilized in line with the company’s approved business plan. As per Entrackr’s estimates, DrinkPrime’s valuation has jumped to Rs 340 crore (approximately $37 million) in the latest round compared to Rs 261 crore in its previous funding round. Following the allotment in the latest round, Artha Continuum Fund and Mirabilis Investment Trust hold a 2.94% stake each in DrinkPrime on a fully diluted basis. The Bengaluru-based startup had previously raised $3 million in a funding round led by SIDBI Venture Capital Ltd. Founded in 2016 by Vijender Reddy Muthyala and Manas Ranjan Hota, DrinkPrime operates a subscription-based water purifier platform that offers IoT-enabled purifiers to households. DrinkPrime reported a 54% increase in operating revenue to Rs 72.13 crore in FY25 from Rs 46.81 crore in FY24, while its loss decreased to Rs 11.53 crore from Rs 14.14 crore during the same period.

Exclusive: Accel-backed biotech startup Mynvax raises fresh funds

EntrackrEntrackr · 1y ago
Exclusive: Accel-backed biotech startup Mynvax raises fresh funds
Medial

Biotech startup Mynvax has raised Rs 21.63 crore ($2.6 million approximately) in an extended Series A round led by Inviga Healthcare Fund. This is a fresh round of investment for the Bengaluru-based company after a hiatus of almost three years. The board at Mynvax has passed a special resolution to issue 5,127 Series A1 CCPS at an issue price of Rs 42,182 per share to raise Rs 21.63 crore, its regulatory filing accessed from RoC shows. Inviga Healthcare Fund invested Rs 15 crore while Legacy Assets LLP pumped in Rs 2 crore. The rest of the capital came from 27 other investors in small proportions. As per TheKredible’s estimates, Mynvax is valued at around Rs 257 crore or $31 million post-money. Mynvax has raised around $9-10 million to date including a $4.2 million Series A round led by Accel and with the participation of Lets Venture, 1Cword, Kotak Investments, and others. Following the fresh process, Accel remains the largest external stakeholder with 15.63% shares followed by Kotak Investment and Invigia. Its co-founders Raghavan Varadarjan and Gautam Nadig cumulatively command a 24.7% stake in the company. Head to TheKredible for the complete shareholding pattern. Founded in 2017, Mynvax develops novel, engineered protein subunit vaccines using their technology for protein stabilization. The company made influenza vaccine and thermo-tolerant, efficacious vaccines for protection against SARS-CoV-2 and its evolving variants in recent years. Mynvax’s revenue from operations grew 89% to Rs 10.94 crore during the fiscal year ending March 2023 while its losses stood at Rs 6.43 crore in the same period. The company is yet to file its financial statements for the last fiscal year (FY24).

Download the medial app to read full posts, comements and news.